Published in Eur J Pediatr on January 01, 1995
The Saccharomyces cerevisiae RNase mitochondrial RNA processing is critical for cell cycle progression at the end of mitosis. Genetics (2002) 1.34
The inherited bone marrow failure syndromes. Pediatr Clin North Am (2013) 0.97
Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet (1992) 15.62
Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med (1990) 2.86
Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell (2001) 2.86
Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet (1995) 2.43
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet (1995) 2.30
Identification of a novel common genetic risk factor for lumbar disk disease. JAMA (2001) 2.28
Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis (1997) 2.08
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Familial aniridia and translocation t(4;11)(q22;p13) without Wilms' tumor. Hum Genet (1983) 1.83
Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab (2010) 1.80
Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet (1998) 1.72
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant (1990) 1.65
Peripheral blood cell counts in infants with Down's syndrome. Clin Genet (1996) 1.61
Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol (1978) 1.55
Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. Proc Natl Acad Sci U S A (1992) 1.54
Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet (1998) 1.49
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. Am J Hum Genet (1994) 1.45
Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr Infect Dis J (1994) 1.44
Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J Pediatr (2001) 1.43
Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. Eur J Pediatr (1993) 1.43
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant (2005) 1.40
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Four pairs of siblings with acute leukemia during 1966-1985 in the Nordic countries: indication of an elevated familial risk? Pediatr Hematol Oncol (1990) 1.39
Colony formation by megakaryocyte progenitors in myelodysplatic syndromes. Eur J Haematol (1989) 1.39
Expression of X-linked hypohidrotic ectodermal dysplasia in six males and in their mothers. Clin Genet (1985) 1.35
Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J Med Genet (2004) 1.30
Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nat Genet (1993) 1.30
Diastrophic dysplasia gene maps to the distal long arm of chromosome 5. Proc Natl Acad Sci U S A (1990) 1.26
Maternal vitamin D status affects bone growth in early childhood--a prospective cohort study. Osteoporos Int (2010) 1.23
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant (1997) 1.19
Cerebroretinal microangiopathy with calcifications and cysts. Neurology (2006) 1.16
Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. N Engl J Med (1987) 1.14
Hearing loss in children with osteogenesis imperfecta. Eur J Pediatr (2000) 1.14
Pallister-Killian syndrome: cytogenetic and molecular studies. Clin Genet (1987) 1.13
Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant (2004) 1.12
Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant (2003) 1.11
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production. Matrix Biol (1998) 1.10
Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr (1998) 1.09
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr (1976) 1.08
Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant (2001) 1.08
Cerebroretinal microangiopathy with calcifications and cysts, Revesz syndrome and aplastic anemia. Bone Marrow Transplant (2012) 1.07
Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet (1980) 1.04
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia (2002) 1.03
Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand J Haematol (1984) 1.03
Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr (1993) 1.03
Experience of severe hypoglycaemia may influence both patient's and physician's subsequent treatment policy of insulin-dependent diabetes mellitus. Eur J Pediatr (1998) 1.02
Chondrosarcoma in a family with multiple hereditary exostoses. J Bone Joint Surg Br (2000) 1.02
Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child (1988) 1.02
Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant (1990) 1.01
Cellular and humoral immmunity in cartilage-hair hypoplasia. Pediatr Res (1978) 1.01
Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis. Bone Marrow Transplant (1993) 1.01
Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood (1989) 1.00
Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions. J Med Genet (2002) 1.00
High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant (2003) 0.99
Defective chemotaxis in monosomy-7. Nature (1977) 0.99
Familial asphyxiating thoracic dysplasia: clinical variability and impact of improved neonatal intensive care. J Pediatr (2001) 0.98
Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis Rheum (1995) 0.98
Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine. J Pediatr (1980) 0.98
Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med (1997) 0.98
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet (2011) 0.97
Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood (1991) 0.97
Alterations in copper and collagen metabolism in the Menkes syndrome and a new subtype of the Ehlers-Danlos syndrome. Biochemistry (1983) 0.97
Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol (2001) 0.97
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. Bone Marrow Transplant (2012) 0.96
Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol (2001) 0.96
An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis (1987) 0.96
Function of neutrophils in preleukaemia. Scand J Haematol (1977) 0.95
Left ventricular function in children with the Marfan syndrome. Eur Heart J (1994) 0.95
Cartilage-hair hypoplasia. J Med Genet (1995) 0.94
Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis (1994) 0.94
Collection of autologous blood for bone marrow donation: how useful is it? Bone Marrow Transplant (2005) 0.93
Foot deformities in diastrophic dysplasia. An analysis of 102 patients. J Bone Joint Surg Br (1992) 0.93
Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood (1986) 0.93
Aortic distensibility in children with the Marfan syndrome. Am J Cardiol (1992) 0.92
Use of bronchoalveolar lavage cytology and determination of protein contents in pulmonary complications of bone marrow transplant recipients. Bone Marrow Transplant (1990) 0.92
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant (2008) 0.91
The effect of oral glucose tolerance test on serum osteocalcin and bone turnover markers in young adults. Calcif Tissue Int (2011) 0.91
Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation. Am J Hum Genet (1999) 0.91
Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients. Clin Infect Dis (2007) 0.91
Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder. J Clin Invest (1982) 0.91
Heme arginate treatment for myelodysplastic syndromes. Leuk Res (1988) 0.91
High-resolution genetic mapping of the cartilage-hair hypoplasia (CHH) gene in Amish and Finnish families. Genomics (1994) 0.90